Amlodipine and Benazepril Hydrochloride (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Amlodipine and Benazepril Hydrochloride drug offered from Actavis Pharma, Inc.. This Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
| NON-PROPRIETARY NAME: | Amlodipine and Benazepril Hydrochloride |
| SUBSTANCE NAME: | AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2010-10-15 |
| END MARKETING DATE: | 0000-00-00 |
Amlodipine and Benazepril Hydrochloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | Amlodipine and Benazepril Hydrochloride from Actavis Pharma, Inc. |
| LABELER NAME: | Actavis Pharma, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2.5; 10(mg/1; mg/1) |
| START MARKETING DATE: | 2010-10-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0591-3757_7204079b-b212-4f9e-a6d7-a9c7ab7d37f2 |
| PRODUCT NDC: | 0591-3757 |
| APPLICATION NUMBER: | ANDA077890 |
Other AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
